MSCLF Projected Dividend Yield

Satellos Bioscience Inc ( OTCBB : MSCLF )

Satellos Bioscience is a biotechnology and drug development. Co. has two portfolios: intellectual property, trademarks and know-how under development by Pre-Arrangement Satellos (the Satellos Portfolio); and intellectual property and assets acquired through the Arrangement (the iCo Portfolio). The technologies in the Satellos Portfolio are based on biological discoveries in the area of muscle stem cells regulation and muscle regeneration. Co.'s technologies within the iCo Portfolio: Oral Amp B Delivery System, which is an oral transport technology; and iCo-008, which is a human monoclonal antibody that neutralizes eotaxin-1, a ligand to the C-C chemokine receptor type three.

20 YEAR PERFORMANCE RESULTS

MSCLF Dividend History Detail
MSCLF Dividend News
MSCLF Competitors News
# of Shares: 0 Closing Price: 0.70 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor